DE68924722D1 - Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel. - Google Patents

Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel.

Info

Publication number
DE68924722D1
DE68924722D1 DE68924722T DE68924722T DE68924722D1 DE 68924722 D1 DE68924722 D1 DE 68924722D1 DE 68924722 T DE68924722 T DE 68924722T DE 68924722 T DE68924722 T DE 68924722T DE 68924722 D1 DE68924722 D1 DE 68924722D1
Authority
DE
Germany
Prior art keywords
derivative
preparation
agents containing
bactericidal agents
benzoxazinorifamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68924722T
Other languages
English (en)
Other versions
DE68924722T2 (de
Inventor
Fumihiko Kanoo
Takehiko Yamane
Hideo Kondo
Takuji Hashizume
Katsuji Yamashita
Kazunori Hosoe
Fumiyuki Joi Shimogamo Kuze
Kiyoshi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Activbiotics Inc
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Publication of DE68924722D1 publication Critical patent/DE68924722D1/de
Application granted granted Critical
Publication of DE68924722T2 publication Critical patent/DE68924722T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE68924722T 1988-03-18 1989-03-15 Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel. Expired - Lifetime DE68924722T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6701488 1988-03-18
JP63239288 1988-09-24

Publications (2)

Publication Number Publication Date
DE68924722D1 true DE68924722D1 (de) 1995-12-14
DE68924722T2 DE68924722T2 (de) 1996-04-18

Family

ID=26408219

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68924722T Expired - Lifetime DE68924722T2 (de) 1988-03-18 1989-03-15 Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel.

Country Status (6)

Country Link
US (1) US4965261A (de)
EP (1) EP0333176B1 (de)
CN (1) CN1020610C (de)
CA (1) CA1293503C (de)
DE (1) DE68924722T2 (de)
ES (1) ES2088870T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756466A (en) 1994-06-17 1998-05-26 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1β converting enzyme
US7122525B2 (en) * 2001-11-21 2006-10-17 Activbiotics, Inc. Targeted therapeutics and uses thereof
US7078399B2 (en) * 2001-12-13 2006-07-18 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
EP1663107A4 (de) * 2003-08-22 2010-06-23 Activbiotics Pharma Llc Rifamycin-analoga und ihre verwendungen
WO2005058231A2 (en) * 2003-12-10 2005-06-30 Activbiotics, Inc. Rifamycin analogs and uses thereof
CN1918172B (zh) * 2003-12-23 2011-09-14 活跃生物工艺学公司 利福霉素类似物及其用途
US7202246B2 (en) * 2004-06-09 2007-04-10 Cumbre Pharmaceuticals Inc. Spiro-rifamycin derivatives targeting RNA polymerase
CA2574307A1 (en) * 2004-07-22 2006-02-02 Cumbre Pharmaceuticals Inc. Rifamycin derivatives for treating microbial infections
EP1968600A4 (de) 2005-12-14 2009-07-15 Activbiotics Pharma Llc Rifamycin-analoga und ihre verwendungen
WO2008008480A2 (en) * 2006-07-12 2008-01-17 Cumbre Pharmaceuticals Inc. Nitroheteroaryl-containing rifamycin derivatives
US7884099B2 (en) 2007-11-16 2011-02-08 Cumbre Ip Ventures, L.P. Quinolone carboxylic acid-substituted rifamycin derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130099C (de) * 1963-10-11
US4005077A (en) * 1965-08-24 1977-01-25 Ciba-Geigy Corporation Antibiotically active compounds
US4690919A (en) * 1984-01-04 1987-09-01 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Benzoxazinorifamycin derivative, process for preparing the same and antibacterial agent containing the same
JPS63183587A (ja) * 1985-02-05 1988-07-28 Kanegafuchi Chem Ind Co Ltd ベンゾキサジノリフアマイシン誘導体
JP2544375B2 (ja) * 1986-07-14 1996-10-16 鐘淵化学工業株式会社 アルキル置換ベンゾキサジノリフアマイシン誘導体

Also Published As

Publication number Publication date
EP0333176A3 (de) 1991-03-20
DE68924722T2 (de) 1996-04-18
EP0333176B1 (de) 1995-11-08
CN1020610C (zh) 1993-05-12
CN1036576A (zh) 1989-10-25
ES2088870T3 (es) 1996-10-01
EP0333176A2 (de) 1989-09-20
US4965261A (en) 1990-10-23
CA1293503C (en) 1991-12-24

Similar Documents

Publication Publication Date Title
DE3769174D1 (de) Indolizin-derivate, verfahren zur herstellung und diese enthaltende zusammensetzungen.
DE68919650D1 (de) 3'-Hydroxysubstituiertes Benzoxazinorifamycinderivat, Verfahren zu seiner Herstellung und dieses enthaltendes antibakterielles Mittel.
DE68924722D1 (de) Substituiertes Benzoxazinorifamycinderivat, Verfahren zur Herstellung und dieses Derivat enthaltende Bakterizidmittel.
DE69012650D1 (de) Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung.
DE59105348D1 (de) Verfahren zur Herstellung von 1,4-Alkylendiaminen.
DE58907033D1 (de) Verfahren zur Herstellung von gegebenenfalls substituierten Benzyl-benzolen.
DE69006911D1 (de) Verfahren zur Herstellung von 3,4-Dichloranilin.
DE69220708D1 (de) Verfahren zur Herstellung von 2,2,6,6,-Tetramethyl-4-Amino-Piperidilen
DE59102357D1 (de) Verfahren zur Herstellung von Diphenylaminen.
DE59200298D1 (de) Verfahren zur Herstellung von 2,4-Dichlorfluorbenzol.
DE59103466D1 (de) Verfahren zur Herstellung von Alkylydroxyanilino-triazinthioderivaten.
DE68923159D1 (de) Verfahren zur Herstellung von 1,4-Dihydropyridin-Derivaten.
DE69321012D1 (de) N-substituiertes-3-(substituiertes Hydrazino)-Benzolsulfonamidderivat, Verfahren zur Herstellung und herbizide Zusammensetzungen
DE69115758D1 (de) Verfahren zur Herstellung von 3,5-Difluoranilin und dessen Derivat
DE59203023D1 (de) Verfahren zur Herstellung von Hydroxydiphenylen.
DE69017091D1 (de) Cyclomalto-oligosaccharidderivate und Verfahren zu ihrer Herstellung.
DE59104221D1 (de) Verfahren zur Herstellung von 2,3,5-Trimethyl-p-benzochinon.
DE59106016D1 (de) Verfahren zur Herstellung von 2,3-Dihydrobenzofuranen.
DE3880988D1 (de) Cinnolin-derivate, verfahren zu deren herstellung und diese enthaltende herbizide zusammenstellungen.
DE59203827D1 (de) Verfahren zur Herstellung von 2,2-Bis-hydroxymethyl-butandiol-(1,4).
DE69200795D1 (de) Verfahren zur Herstellung von L-Prolinederivaten.
DE59204105D1 (de) Verfahren zur Herstellung von Difluorbenzaldehyden.
DE59201640D1 (de) Verfahren zur Herstellung von N-Cyanimidocarbonaten.
DE69016922D1 (de) Verfahren zur Herstellung von 17-Estern des 21-Desoxyprednisolons.
DE59300178D1 (de) Verfahren zur Herstellung von 2,5-disubstituierten Pyridinen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ACTIVBIOTICS,INC., LEXINGTON, MASS., US